Capital Fund Management S.A. Crispr Therapeutics Ag Put Options Transaction History

Capital Fund Management S.A.

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $2.25 Million - $3 Million	-44,000 Reduced 37.23%	74,200 $4.01 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $6.12 Million - $8.99 Million	100,900 Added 583.24%	118,200 $8.06 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $189,238 - $353,682	4,900 Added 39.52%	17,300 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $403,971 - $525,100	-8,900 Reduced 41.78%	12,400 $562,000
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $1.13 Million - $1.76 Million	-26,000 Reduced 54.97%	21,300 $1.2 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $270,600 - $370,392	6,600 Added 16.22%	47,300 $2.14 Million
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $82,299 - $137,907	-2,100 Reduced 4.91%	40,700 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $2.62 Million - $3.59 Million	42,800 New	42,800 $2.8 Billion
Q1 2022 May 12, 2022	BUY	$53.19 - $79.24 $2.74 Million - $4.09 Million	51,600 Added 385.07%	65,000 $4.08 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1.05 Million - $1.49 Million	-9,500 Reduced 41.48%	13,400 $1.5 Million
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $110,924 - $178,078	-1,100 Reduced 4.58%	22,900 $3.71 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $1.51 Million - $2.86 Million	13,600 Added 130.77%	24,000 $2.92 Million
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $461,240 - $683,383	10,400 New	10,400 $461,000

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.